Enliven Therapeutics, Inc. (ELVN)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
53. 20
+2.34
+4.6009%
$
3.7B Market Cap
- P/E Ratio
- Div Yield
818,000 Volume
-2.36 Eps
$ 50.86
Previous Close 
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enliven Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Salim Syed Mizuho | 582.14 | $21,696.41 | $30,946.56 | $9,250.15 | 42.63% |
